The altered metabolic pathways of diffuse large B-cell lymphoma not otherwise specified

References

• Sehn LH, Salles G. Diffuse large B-Cell lymphoma. N Engl J Med. 2021;4:842–858.
   Google Scholar
• Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403(6769):503–511. doi:10.1038/35000501
   PubMed Web of Science ®Google Scholar
• Scott DW, Mottok A, Ennishi D, et al. Prognostic significance of diffuse large B-cell lymphoma cell of origin determined by digital gene expression in formalin-fixed paraffin-embedded tissue biopsies. J Clin Oncol. 2015;33(26):2848–2856. Sep 10doi:10.1200/JCO.2014.60.2383
   PubMed Web of Science ®Google Scholar
• Lacy SE, Barrans SL, Beer PA, et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a haematological malignancy research network report. Blood. 2020;135(20):1759–1771. doi:10.1182/blood.2019003535
   PubMed Web of Science ®Google Scholar
• Wright GW, Huang DW, Phelan JD, et al. A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications. Cancer Cell. 2020;37(4):551–568.e14. doi:10.1016/j.ccell.2020.03.015
   PubMed Web of Science ®Google Scholar
• Pedrosa L, Fernández-Miranda I, Pérez-Callejo D, et al. Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. Sci Rep. 2021;11(1):1886. doi:10.1038/s41598-020-80376-0
   PubMed Web of Science ®Google Scholar
• Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–1748. doi:10.1038/s41375-022-01620-2
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275–282. doi:10.1182/blood-2003-05-1545
   PubMed Web of Science ®Google Scholar
• Meyer PN, Fu K, Greiner TC, et al. Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab. J Clin Oncol. 2011;29(2):200–207. doi:10.1200/JCO.2010.30.0368
   PubMed Web of Science ®Google Scholar
• Gutiérrez-García G, Cardesa-Salzmann T, Climent F, et al. Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Blood. 2011;117(18):4836–4843. doi:10.1182/blood-2010-12-322362
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Beltran BE, Song MK, et al. The hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP. Leuk Res. 2012;36(4):413–417. doi:10.1016/j.leukres.2011.12.012
   PubMed Web of Science ®Google Scholar
• Song JY, Dirnhofer S, Piris MA, et al. Difuse large B‑cell lymphomas, not otherwise specifed, and emerging entities. Virchows Arch. 2023;482 (1):179–192. doi:10.1007/s00428-022-03466-6
   PubMedGoogle Scholar
• Xiong J, Wang L, Fei X-C, et al. MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(7):e0. doi:10.1038/bcj.2017.61
   PubMedGoogle Scholar
• Barré FPY, Claes BSR, Dewez F, et al. Specific lipid and metabolic profiles of R‑CHOP-resistant diffuse large B‑cell lymphoma elucidated by matrix-assisted laser desorption ionization mass spectrometry imaging and in vivo imaging. Anal Chem. 2018;90(24):14198–14206. doi:10.1021/acs.analchem.8b02910
   PubMed Web of Science ®Google Scholar
• Gogia A, Nair S, Arora S, et al. Impact of cell-of-origin on outcome of patients with diffuse large B-cell lymphoma treated with uniform R-CHOP protocol: a single-center retrospective analysis from North India. Front Oncol. 2021;11:770747. doi:10.3389/fonc.2021.770747
   PubMedGoogle Scholar
• Schwarzfischer P, Reinders J, Dettmer K, et al. Comprehensive metaboproteomics of Burkitt’s and diffuse large B‑cell lymphoma cell lines and primary tumor tissues reveals distinct differences in pyruvate content and metabolism. J Proteome Res. 2017;16(3):1105–1120. doi:10.1021/acs.jproteome.6b00164
   PubMed Web of Science ®Google Scholar
• Duarte GHB, Fernandes AMAP, Silva AAR, et al. Gas chromatography-mass spectrometry untargeted profiling of non-Hodgkin’s lymphoma urinary metabolite markers. Anal Bioanal Chem. 2020;412(27):7469–7480. doi:10.1007/s00216-020-02881-5
   PubMed Web of Science ®Google Scholar
• Barberini L, Noto A, Fattuoni C, Satta G, Zucca M, Cabras MG, et al. The metabolomic profile of lymphoma subtypes: a pilot study. Molecules. 2019;24(13):2367. doi:10.3390/molecules24132367
   PubMed Web of Science ®Google Scholar
• Gascoyne RD, Campo E, Jaffe ES, et al. Diffuse large B-cell lymphoma, NOS. In: Swerdlow SH, Campo E, Harris NL, eds. World health organization classification of tumours of hematopoietic and lymphoid tissues. Rev., 4th ed., Lyon, France: International Agency for Research on Cancer; 2017:291–297.
   Google Scholar
• Kluin PM, Harris NL, Stein H, et al. High grade B-cell lymphoma. In: swerdlow SH, Campo E, Harris NL, eds. World health organization classification of tumours of hematopoietic and lymphoid tissues. Rev., 4th ed., Lyon, France: International Agency for Research on Cancer; 2017:335–341.
   Google Scholar
• Rodrigues-Fernandes CI, Gonçalves Junior A, Soares CD, et al. Oral and oropharyngeal diffuse large B-cell lymphoma and high-grade B-cell lymphoma: a clinicopathologic and prognostic study of 69 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(4):452–462.e4. doi:10.1016/j.oooo.2020.11.005
   PubMed Web of Science ®Google Scholar
• Libiseller G, Dvorzak M, Kleb U, et al. IPO: a tool for automated optimization of XCMS parameters. BMC Bioinf. 2015;16(1):1–10. doi:10.1186/s12859-015-0562-8
   PubMedGoogle Scholar
• Domingo-Almenara X, Siuzdak G. Metabolomics data processing using XCMS. In S. Li editor. Computational methods and data analysis for metabolomics. Springer US; Berlin, Germany, 2020 p. 11–24.
   Google Scholar
• Smith CA, Want EJ, O'Maille G, et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78(3):779–787. doi:10.1021/ac051437y
   PubMed Web of Science ®Google Scholar
• Pang Z, Chong J, Zhou G, et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388–W396. doi:10.1093/nar/gkab382
   PubMed Web of Science ®Google Scholar
• Xia J, Wishart DS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6(6):743–760. doi:10.1038/nprot.2011.319
   PubMed Web of Science ®Google Scholar
• Chong J, Wishart DS, Xia J. Using metaboanalyst 5.0 for comprehensive and integrative metabolomics data analysis. Curr Protoc Bioinforma. 2019;68:1–128.
   Google Scholar
• Gromski PS, Muhamadali H, Ellis DI, et al. A tutorial review: metabolomics and partial least squares-discriminant analysis–a marriage of convenience or a shotgun wedding. Anal Chim Acta. 2015;879:10–23. doi:10.1016/j.aca.2015.02.012
   PubMed Web of Science ®Google Scholar
• Li S, Park Y, Duraisingham S, et al. Predicting network activity from high throughput metabolomics. PLOS Comput Biol. 2013;9(7):e1003123. doi:10.1371/journal.pcbi.1003123
   PubMed Web of Science ®Google Scholar
• Arima K, Lau MC, Zhao M, et al. Metabolic profiling of formalin-fixed paraffin-embedded tissues discriminates normal colon from colorectal cancer. Mol Cancer Res. 2020;18(6):883–890. doi:10.1158/1541-7786.MCR-19-1091
   PubMed Web of Science ®Google Scholar
• Neef SK, Winter S, Hofmann U, et al. Optimized protocol for metabolomic and lipidomic profiling in formalin-fixed paraffin-embedded kidney tissue by LC-MS. Anal Chim Acta. 2020;1134:125–135. doi:10.1016/j.aca.2020.08.005
   PubMed Web of Science ®Google Scholar
• Bao X, Wu J, Shuch B, et al. Quantitative profiling of oncometabolites in frozen and formalin-fixed paraffin-embedded tissue specimens by liquid chromatography coupled with tandem mass spectrometry. Sci Rep. 2019;9(1):11238. doi:10.1038/s41598-019-47669-5
   PubMedGoogle Scholar
• Yarla NS, Bishayee A, Sethi G, et al. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol. 2016;41:48–81.
   Web of Science ®Google Scholar
• Wang B, Wu L, Chen J, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6:94.
   PubMed Web of Science ®Google Scholar
• Xia X, Sadeghi L, Strååt K, et al. Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells. Prostaglandins Other Lipid Mediat. 2021;156:106575. doi:10.1016/j.prostaglandins.2021.106575
   PubMed Web of Science ®Google Scholar
• Wang Q, Morris RJ, Bode AM, et al. Prostaglandin pathways: opportunities for cancer prevention and therapy. Cancer Res. 2022;82(6):949–965. doi:10.1158/0008-5472.CAN-21-2297
   PubMed Web of Science ®Google Scholar
• Jara-Gutiérrez Á, Baladrón V. The role of prostaglandins in different types of cancer. Cells. 2021;10(6):1487. doi:10.3390/cells10061487
   PubMed Web of Science ®Google Scholar
• Pandey VK, Amin PJ, Shankar BS. COX-2 inhibitor prevents tumor induced down regulation of classical DC lineage specific transcription factor Zbtb46 resulting in immunocompetent DC and decreased tumor burden. Immunol. Lett. 2017;184:23–33. doi:10.1016/j.imlet.2017.01.019
   PubMed Web of Science ®Google Scholar
• Runarsson G, Liu A, Mahshid Y, et al. Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells. Blood. 2005;105(3):1274–1279. doi:10.1182/blood-2004-07-2546
   PubMed Web of Science ®Google Scholar
• Jiang Q. Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radic Biol Med. 2014;72:76–90. doi:10.1016/j.freeradbiomed.2014.03.035
   PubMed Web of Science ®Google Scholar
• Park NY, Im S, Jiang Q. Different forms of vitamin E and metabolite 13'-carboxychromanols inhibit cyclooxygenase-1 and its catalyzed thromboxane in platelets, and tocotrienols and 13'-carboxychromanols are competitive inhibitors of 5-lipoxygenase. J Nutr Biochem. 2022;100:108884. doi:10.1016/j.jnutbio.2021.108884
   PubMed Web of Science ®Google Scholar
• Schain F, Schain D, Mahshid Y, et al. Differential expression of cysteinyl leukotriene receptor 1 and 15-lipoxygenase-1 in non-Hodgkin lymphomas. Clin Lymphoma Myeloma. 2008;8(6):340–347. doi:10.3816/CLM.2008.n.049
   PubMedGoogle Scholar
• Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645–662. doi:10.1111/j.1365-2125.2012.04374.x
   PubMed Web of Science ®Google Scholar
• Aktaş S, Ercetin P, Altun Z, et al. Safety of eicosapentaenoic acid in cancer treatment: effect on cancer cells and chemotherapy in vitro. Nutr Cancer. 2021;73(4):568–571. doi:10.1080/01635581.2020.1781201
   PubMed Web of Science ®Google Scholar
• Bar-El Dadon S, Reifen R. Vitamin A and the epigenome. Crit Rev Food Sci Nutr. 2017;57(11):2404–2411. doi:10.1080/10408398.2015.1060940
   PubMed Web of Science ®Google Scholar
• Carazo A, Macáková K, Matoušová K, et al. Vitamin A update: forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity. Nutrients. 2021;13(5):1703. doi:10.3390/nu13051703
   PubMed Web of Science ®Google Scholar
• Jiang Q. Metabolism of natural forms of vitamin E and biological actions of vitamin E metabolites. Free Radic Biol Med. 2022;179:375–387. doi:10.1016/j.freeradbiomed.2021.11.012
   PubMed Web of Science ®Google Scholar
• Morimoto Y, Ollberding NJ, Cooney RV, et al. Prediagnostic serum tocopherol levels and the risk of non-Hodgkin lymphoma: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2013;22(11):2075–2083. doi:10.1158/1055-9965.EPI-13-0522
   PubMed Web of Science ®Google Scholar
• Jiang Q. Natural forms of vitamin E and metabolites-regulation of cancer cell death and underlying mechanisms. IUBMB Life. 2019;71:495–506.
   PubMed Web of Science ®Google Scholar
• Sharma R, Vinayak M. Antioxidant a -tocopherol checks lymphoma promotion via regulation of expression of protein kinase C-alpha a and c-Myc genes and glycolytic metabolism. Leuk Lymphoma. 2012;53(6):1203–1210. doi:10.3109/10428194.2011.637213
   PubMed Web of Science ®Google Scholar
• Sharma R, Vinayak M. α-Tocopherol prevents lymphoma by improving antioxidant defence system of mice. Mol Biol Rep. 2013;40(2):839–849. doi:10.1007/s11033-012-2123-9
   PubMed Web of Science ®Google Scholar
• de Nigris F, Youssef T, Ciafré S, et al. Evidence for oxidative activation of c-Myc-dependent nuclear signaling in human coronary smooth muscle cells and in early lesions of Watanabe heritable hyperlipidemic rabbits: protective effects of vitamin E. Circulation. 2000;102(17):2111–2117. doi:10.1161/01.cir.102.17.2111
   PubMed Web of Science ®Google Scholar
• Calvisi DF, Ladu S, Hironaka K, et al. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J Hepatol. 2004;41(5):815–822. doi:10.1016/j.jhep.2004.07.030
   PubMed Web of Science ®Google Scholar
• Tamási V, Monostory K, Prough RA, et al. Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s. Cell Mol Life Sci. 2011;68(7):1131–1146. doi:10.1007/s00018-010-0600-7
   PubMed Web of Science ®Google Scholar
• Patterson AD, Gonzalez FJ, Idle JR. Xenobiotic metabolism: a view through the metabolometer. Chem Res Toxicol. 2010;23(5):851–860. doi:10.1021/tx100020p
   PubMed Web of Science ®Google Scholar
• Reszka E, Wasowicz W, Gromadzinska J. Genetic polymorphism of xenobiotic metabolising enzymes, diet and cancer susceptibility. Br J Nutr. 2006; 96(4):609–619.
   PubMed Web of Science ®Google Scholar
• Li W, Lu Z, Pan D, et al. Gene expression analysis reveals prognostic biomarkers of the tyrosine metabolism reprogramming pathway for prostate cancer. J Oncol. 2022;2022:5504173.
   PubMed Web of Science ®Google Scholar
• Kelly AD, Breitkopf SB, Yuan M, et al. Metabolomic profiling from formalin-fixed, paraffin- embedded tumor tissue using targeted LC/MS/MS: application in sarcoma. PLOS One. 2011;6(10):e25357. doi:10.1371/journal.pone.0025357
   PubMed Web of Science ®Google Scholar
• Cacciatore S, Zadra G, Bango C, et al. Metabolic profiling in formalin-fixed and paraffin-embedded prostate cancer tissues. Mol Cancer Res. 2017;15(4):439–447. doi:10.1158/1541-7786.MCR-16-0262
   PubMed Web of Science ®Google Scholar
• Bastos VC, Vitório JG, Martins-Chaves RR, et al. Age-related metabolic pathways changes in dental follicles: a pilot study. Front Oral Health. 2021;2:677731. doi:10.3389/froh.2021.677731
   PubMedGoogle Scholar